Currently viewing the tag: "Fusilev"

Spectrum a future Winner

By On 9. June 2012 · Leave a Comment · In Spectrum

Being a  Danish investor I first learned about Spectrum Pharmaceuticals back in 2010, when Spectrum and Danish TopoTarget entered into an agreement on HDACi inhibitor Belinostat.

After having read extensively about the possibilities of Spectrum I decided to make a investment  in 2010, at the time the stock was trading in the 4-5 dollar range. Today […]

Continue Reading →
Set your Twitter account name in your settings to use the TwitterBar Section.